PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC is reminding investors with substantial losses in PROCEPT BioRobotics (NasdaqGM: PRCT) that they have until September 22, 2026 to file lead plaintiff applications in a pending securities class action in the U.S. District Court for the Northern District of California (No. 26-cv-07691), covering purchasers between February 28, 2024 and February 25, 2026. The suit alleges Procept and certain executives failed to disclose that U.S.
Key figures
- Court
- U.S. District Court, Northern District of California
- Case number
- No. 26-cv-07691
- Class period
- February 28, 2024 to February 25, 2026
- Stock decline pct
- more than 18% over a two-day trading period
- Q3 us handpiece units
- 13225
- Q4 us handpiece units
- 9400
- Share price feb25 2026
- 27.84
- Share price feb27 2026
- 22.69
- Lead plaintiff deadline
- September 22, 2026
- Sequential unit decline
- nearly 30%
- Excess field inventory units
- more than 10,000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.